Bersani C, Bertoletti R, Colombo M L, Merlini C, Uccelli M, Fietta A, Gialdroni Grassi G
Chair of Chemotherapy, University of Pavia, Italy.
Chemioterapia. 1987 Dec;6(6):420-5.
We studied the effects of rifamycin SV, rifampicin and rifapentine on human phagocyte functions. Rifamycins inhibited in vitro neutrophil chemotaxis in the range of their therapeutic levels, and they significantly affected the survival of a rifamycin-sensitive strain of Staphylococcus aureus inside human monocytes. Both effects were related to the intraphagocytic penetration of these antibiotics. For the ex vivo studies, 600 mg of rifampicin were orally administered to five subjects with defective S. aureus killing. A significant reduction of neutrophil chemotaxis and increased activity against S. aureus were shown 150 and 210 min after administration of the drug.
